Magnetar Financial LLC lifted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 124.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 72,227 shares of the healthcare conglomerate's stock after purchasing an additional 39,988 shares during the period. Magnetar Financial LLC's holdings in UnitedHealth Group were worth $36,537,000 at the end of the most recent reporting period.
Several other large investors have also recently bought and sold shares of UNH. State Street Corp grew its position in shares of UnitedHealth Group by 1.3% in the 3rd quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate's stock valued at $26,626,387,000 after buying an additional 563,554 shares during the last quarter. Geode Capital Management LLC lifted its holdings in shares of UnitedHealth Group by 1.6% in the 3rd quarter. Geode Capital Management LLC now owns 19,636,704 shares of the healthcare conglomerate's stock valued at $11,440,133,000 after purchasing an additional 318,039 shares during the last quarter. Franklin Resources Inc. grew its stake in UnitedHealth Group by 2.5% during the 3rd quarter. Franklin Resources Inc. now owns 8,061,916 shares of the healthcare conglomerate's stock worth $4,884,019,000 after buying an additional 193,800 shares during the last quarter. Bank of New York Mellon Corp boosted its holdings in shares of UnitedHealth Group by 0.5% in the fourth quarter. Bank of New York Mellon Corp now owns 7,931,478 shares of the healthcare conglomerate's stock valued at $4,012,218,000 after acquiring an additional 36,394 shares during the period. Finally, Charles Schwab Investment Management Inc. increased its holdings in shares of UnitedHealth Group by 3.0% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 6,223,331 shares of the healthcare conglomerate's stock valued at $3,148,134,000 after acquiring an additional 182,361 shares during the period. Hedge funds and other institutional investors own 87.86% of the company's stock.
Analyst Ratings Changes
A number of equities research analysts have recently commented on the stock. StockNews.com raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a report on Thursday, January 23rd. Stephens boosted their target price on UnitedHealth Group from $605.00 to $675.00 and gave the company an "overweight" rating in a report on Thursday, December 5th. Oppenheimer lifted their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an "outperform" rating in a research report on Friday, December 6th. Truist Financial lowered their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating on the stock in a report on Monday, January 6th. Finally, KeyCorp restated an "overweight" rating and issued a $650.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Twenty research analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Buy" and a consensus price target of $629.32.
View Our Latest Stock Analysis on UNH
UnitedHealth Group Trading Up 0.0 %
Shares of UNH traded up $0.09 during mid-day trading on Monday, hitting $516.94. The company had a trading volume of 3,840,856 shares, compared to its average volume of 4,087,243. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The business's 50-day simple moving average is $510.19 and its 200-day simple moving average is $546.71. The stock has a market cap of $472.85 billion, a PE ratio of 33.35, a P/E/G ratio of 1.37 and a beta of 0.62.
UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business's quarterly revenue was up 6.8% on a year-over-year basis. During the same period last year, the company posted $5.83 EPS. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were given a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.62%. UnitedHealth Group's dividend payout ratio (DPR) is 54.19%.
Insider Buying and Selling at UnitedHealth Group
In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of the company's stock in a transaction dated Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares in the company, valued at $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.33% of the stock is currently owned by corporate insiders.
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
